Inventor · disambiguated record
Xiaoqiang Kang
Also filed as: KANG XIAOQIANG
7 granted patents·3 pending applications·2 citations·filing 2004–2023
71Inventor score
Top patents by PatentIndex Score
10 records- 0168US7951370B2Anti-TYRP1 antibodiesIMCLONE LLC·Filed 2009·Granted May 31, 2011·2 cites·8 claims
- 0268US2024025967A1Recombinant protein targeting pd-1 and tgfbetaNANJING LEADS BIOLABS CO LTD·Filed 2023·Application pending·0 cites
- 0365US2023192862A1Antibodies binding 4-1bb and uses thereofNANJING LEADS BIOLABS CO LTD·Filed 2022·Application pending·0 cites
- 0463US11466086B2Antibodies binding 4-1BB and uses thereofNANJING LEADS BIOLABS CO LTD·Filed 2020·Granted Oct 11, 2022·0 cites·20 claims
- 0561US11802145B2Recombinant protein targeting PD-1 and TGFßNANJING LEADS BIOLABS CO LTD·Filed 2020·Granted Oct 31, 2023·0 cites·17 claims
- 0655US11912777B2Antibodies binding TNFR2 and uses thereofNANJING LEADS BIOLABS CO LTD·Filed 2022·Granted Feb 27, 2024·0 cites·30 claims
- 0746US11136394B2Antibody binding PD-1 and use thereofNANJING LEADS BIOLABS CO LTD·Filed 2019·Granted Oct 5, 2021·0 cites·24 claims
- 0844US11807683B2Antibody binding TIM-3 and use thereofNANJING LEADS BIOLABS CO LTD·Filed 2019·Granted Nov 7, 2023·0 cites·23 claims
- 0942US2004132972A1Tri-hybrid melanoma antigenFiled 2004·Application pending·0 cites
- 1040US10844121B2Antibodies binding LAG-3 and uses thereofNANJING LEADS BIOLABS CO LTD·Filed 2018·Granted Nov 24, 2020·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →